Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Pradeep Kumar Sacitharan has won the European Calcified Tissue Society (ECTS) New Investigator Award at their annual conference in Rome, Italy. ECTS is Europe's major organisation for researchers and clinicians working in musculoskeletal sciences.

Pradeep presented his findings on ageing pathways which fail in cartilage leading to osteoarthritis. Speaking of his award, he said: "I am delighted to receive this award. This recognition at the European level encourages me to work even harder to reach my research goals and dreams".

The ECTS New Investigator Award recognises young investigators who submit top-ranking abstracts based on scientific merit to the ECTS annual meeting.

Pradeep is supervised by Dr James Edwards and Professor Tonia Vincent and previously also won a British new investigator award.

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.